title: Endemicity of onchocerciasis in some local government areas of Niger state.
abstract: The established method of justifying the need for ivermectin delivery to a community is the use of Rapid Assessment Method (RAM). This method involves the clinical examination of 50 adult males, who have been resident in the community for at least five years, for onchocercal nodules and leopard skin. The values obtained for these indices will guide the classification of such a community as being hypoendemic, mesoendemic or hyperendemic. Those that fall within mesoendemic and hyperendemic category onchocerciasis qualify for ivermectin delivery. This study was carried out to determine the endemicity level of onchocerciasis in 74 communities of 8 Local Government Areas (LGAs) of Niger state to justify their inclusion or otherwise in the ongoing state wide mass treatment for onchocerciasis using ivermectin. The communities were selected using the Geographical Information System (GIS) data and following the World Health Organization (WHO) guideline for RAM. A total of 3000 subjects were examined comprising of 2395 (79.8%) males and 605 (20.2%) females. None of the LGAs, based on overall prevalence for nodules qualify for mass treatment with ivermectin. However the study identified communities within some of these LGAs that were mesoendemic for onchocerciasis and thus qualified for mass treatment with ivermectin.
authors.affiliation: Public Health Division, Nigerian Institute of Medical Research, P.M.B 2013, Yaba, Lagos, Nigeria.
authors.forename: E T
authors.initials: ET
authors.lastname: Idowu
authors.forename: B
authors.initials: B
authors.lastname: Adewale
authors.forename: M A
authors.initials: MA
authors.lastname: Mafe
authors.forename: B
authors.initials: B
authors.lastname: Appelt
authors.forename: A
authors.initials: A
authors.lastname: Bamgbose
mesh_terms: D000871:Anthelmintics / Q000600:supply & distribution / Q000627:therapeutic use; D019353:Endemic Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007559:Ivermectin / Q000600:supply & distribution / Q000627:therapeutic use; D008297:Male; D009549:Nigeria / Q000453:epidemiology; D009855:Onchocerciasis / Q000453:epidemiology* / Q000517:prevention & control; D011159:Population Surveillance / Q000379:methods*; D015980:Public Health Practice; D019371:Topography, Medical / Q000379:methods*
chemical_list: D000871:Anthelmintics; D007559:Ivermectin